DBV Technologies Granted US Patents for Allergen Delivery System VIASKIN

27-Sep-2010 - DBV Technologies (DBV) announced that its unique VIASKIN® delivery system has been granted two US patents. In both cases, the lifetime of the patent has been extended until 2026. Aspects of both patents (US 7,635,488 and US 7,722,897) are incorporated into DBV Technologies’ VIASKIN which delivers ...

DBV Technologies expands scientific advisory board

16-Jun-2010 - DBV Technologies (DBV) announced the appointment of leading paediatric allergy and allergy specialists Professor N Franklin Adkinson Jr MD and Associate Professor Jonathan M Spergel MD to its Scientific Advisory Board. These SAB appointments are of strategic importance to DBV Technologies, as the ...

DBV Technologies expands Scientific Advisory Board

23-Dec-2009 - DBV Technologies (DBV) announced the appointment of US-based food allergy and paediatric asthma specialist Professor Robert Zeiger to its Scientific Advisory Board. In joining the Scientific Advisory Board, Professor Zeiger will provide DBV Technologies’ with access to his expertise in food ...

DBV Technologies increases expertise in peanut allergy diagnosis and treatment with SAB appointments

DBV Technologies Expands Scientific Advisory Board with Appointment of Food and Paediatric Allergy Specialists

21-Oct-2009 - DBV Technologies announced the expansion of its Scientific Advisory Board with the appointments of paediatric allergy and paediatric food allergy specialists Professor Gideon Lack and Associate Professor Philippe Eigenmann. In joining DBV Technologies’ Scientific Advisory Board, Professors Lack ...

DBV Technologies Expands Board of Directors

23-Feb-2009 - DBV Technologies (DBV), a biopharmaceutical company specialising in the development of non-invasive epicutaneous diagnostics and immunotherapies for allergies, announced that it has expanded its Board of Directors with the appointment of Peter Barton Hutt as Non-Executive Director. Hutt brings ...